Drug intelligence / Profile preview

Floradapt Intensive GI

Development stage: Unknown
Lead developer: Kaneka
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Floradapt Intensive GI is a clinically tested, multi-strain probiotic dietary supplement designed to optimize gastrointestinal function and promote gut comfort. It contains three specific strains of probiotics—Pediococcus acidilactici KABP 021, Lactobacillus plantarum KABP 022, and Lactobacillus plantarum KABP 023—selected from wild strains for their high performance in supporting gut health. The formulation has demonstrated benefits in reducing symptoms associated with irritable bowel syndrome (IBS), such as abdominal pain, bloating, gas, constipation, and diarrhea. Clinical trials have shown that daily use can improve overall gut health and microbial balance while also positively impacting the gut-brain axis to support mental wellbeing. The product is shelf-stable and backed by published clinical research[2][3][5].

Brand names: Floradapt Intensive GI
Other names: Purica Floradapt Intensive GI

Beyond the preview

Go deeper on Floradapt Intensive GI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Floradapt Intensive GI.

Explore the full profile